Glaucoma Risk Factors: Fluctuations in Intraocular Pressure

  • Felipe A. Medeiros


Intraocular pressure (IOP) has been consistently demonstrated to be associated with incidence, prevalence, and progression of glaucoma. However, although there is strong evidence to support mean IOP as a risk factor for both development and progression of the disease, there is uncertainty with regard to the role of IOP fluctuations in glaucoma. One of the difficulties in investigating this relationship comes from the concept of IOP fluctuation. Some authors define fluctuation as variation in IOP during the diurnal period. Others include the nocturnal period as well and point out that one should look at 24-h fluctuation as an important parameter for glaucoma progression. Finally, others have defined IOP fluctuation as the variability in IOP measurement between visits, which is often called long-term fluctuation. The role of very short-term fluctuations in IOP is explored in Sidebar 4.1.


Ocular Hypertension Visual Field Loss Trabecular Meshwork Cell Glaucoma Progression Outflow Facility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Singh K, Shrivastava A. Intraocular pressure fluctuations: how much do they matter? Curr Opin Ophthalmol. 2009;20(2):84–87.CrossRefPubMedGoogle Scholar
  2. 2.
    Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111(9):1627–1635.CrossRefPubMedGoogle Scholar
  3. 3.
    The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440.CrossRefGoogle Scholar
  4. 4.
    Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(2):205–209.CrossRefPubMedGoogle Scholar
  5. 5.
    Palmberg P. What is it about pressure that really matters in glaucoma? Ophthalmology. 2007;114(2):203–204.CrossRefPubMedGoogle Scholar
  6. 6.
    Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008;115(7):1123–1129.CrossRefPubMedGoogle Scholar
  7. 7.
    Medeiros FA, Weinreb RN, Zangwill LM, et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology. 2008;115(6):934–940.CrossRefPubMedGoogle Scholar
  8. 8.
    Bengtsson B, Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2005;243(6):513–518.CrossRefPubMedGoogle Scholar
  9. 9.
    Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9(2):134–142.PubMedGoogle Scholar
  10. 10.
    Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003;44(4):1586–1590.CrossRefPubMedGoogle Scholar


  1. Cai S, Liu X, Glasser A, et al. Effect of latrunculin-A on morphology and actin-associated adhesions of cultured human trabecular meshwork cells. Mol Vis. 2000;6:132–143.PubMedGoogle Scholar
  2. Coleman DJ, Trokel S. Direct-recorded intraocular pressure variations in a human subject. Arch Ophthalmol. 1969;82:637–640.PubMedGoogle Scholar
  3. Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40:74–81.PubMedGoogle Scholar
  4. Ethier CR, Read AT, Chan DW. Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes. Invest Ophthalmol Vis Sci. 2006;47:1991–1998.CrossRefPubMedGoogle Scholar
  5. Gabelt BT, Hu Y, Vittitow JL, et al. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res. 2006;82:935–944.CrossRefPubMedGoogle Scholar
  6. Peterson JA, Tian B, Bershadsky AD, et al. Latrunculin-A increases outflow facility in the monkey. Invest Ophthalmol Vis Sci. 1999;40:931–941.PubMedGoogle Scholar
  7. Peterson JA, Tian B, Geiger B, Kaufman PL. Effect of latrunculin-B on outflow facility in monkeys. Exp Eye Res. 2000;70:307–313.CrossRefPubMedGoogle Scholar
  8. Ramos RF, Stamer WD. Effects of cyclic intraocular pressure on conventional outflow facility. Invest Ophthalmol Vis Sci. 2008;49:275–281.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Felipe A. Medeiros
    • 1
  1. 1.Department of OphthalmologyUniversity of California San DiegoLa JollaUSA

Personalised recommendations